249 related articles for article (PubMed ID: 2408735)
1. A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer.
Vogl SE; Schoenfeld DA; Kaplan BH; Lerner HJ; Engstrom PF; Horton J
Cancer; 1985 Aug; 56(3):432-42. PubMed ID: 2408735
[TBL] [Abstract][Full Text] [Related]
2. Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group.
Clavel M; Vermorken JB; Cognetti F; Cappelaere P; de Mulder PH; Schornagel JH; Tueni EA; Verweij J; Wildiers J; Clerico M
Ann Oncol; 1994 Jul; 5(6):521-6. PubMed ID: 7522527
[TBL] [Abstract][Full Text] [Related]
3. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
Amrein PC; Fabian RL
Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of the combination of cis-platinum, oncovin and bleomycin (COB) versus methotrexate in patients with advanced squamous cell carcinoma of the head and neck.
Drelichman A; Cummings G; Al-Sarraf M
Cancer; 1983 Aug; 52(3):399-403. PubMed ID: 6190548
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Gebbia V; Valenza R; Testa A; Borsellino N; Cannata G; Restivo S; Speciale R; Ingria F; Spadafora G; Gebbia N
ORL J Otorhinolaryngol Relat Spec; 1994; 56(5):279-82. PubMed ID: 7526312
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck.
Clavel M; Cognetti F; Dodion P; Wildiers J; Rosso R; Rossi A; Gignoux B; Van Rymenant M; Cortes-Funes H; Dalesio O
Cancer; 1987 Sep; 60(6):1173-7. PubMed ID: 2441836
[TBL] [Abstract][Full Text] [Related]
7. A randomized study of methotrexate, bleomycin, hydroxyurea with versus without cisplatin in patients with previously untreated and recurrent squamous cell carcinoma of the head and neck.
Abele R; Honegger HP; Grossenbacher R; Mermillod B; Kaplan E; Gervasi A; Wolfensberger M; Lehmann W; Cavalli F
Eur J Cancer Clin Oncol; 1987 Jan; 23(1):47-53. PubMed ID: 2439344
[TBL] [Abstract][Full Text] [Related]
8. Alternating combination chemotherapy using cisplatin-bleomycin with sequential methotrexate-5-FU plus leucovorin rescue in patients with head and neck cancer.
Panasci L; Gravenor D; Black M; Frenkiel S; Margolese R
Cancer Treat Rep; 1985 Sep; 69(9):1015-7. PubMed ID: 2411401
[TBL] [Abstract][Full Text] [Related]
9. Mitomycin-C, methotrexate, bleomycin and cis-diamminedichloroplatinum II in the chemotherapy of advanced squamous cancer of the head and neck.
Vogl SE; Lerner H; Kaplan BH; Camacho F; Cinberg J; Schoenfeld D
Cancer; 1982 Jul; 50(1):6-9. PubMed ID: 6177393
[TBL] [Abstract][Full Text] [Related]
10. Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapy.
Recondo G; Armand JP; Tellez-Bernal E; Domenge C; Belehradek M; De Vathaire F; Wibault P; Richard JM; Cvitkovic E
Laryngoscope; 1991 May; 101(5):494-501. PubMed ID: 1709437
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy with cisplatin, methotrexate, bleomycin and vincristine (CABO) in patients with stage III and IV squamous cell carcinoma of the head and neck.
Recloux P; Dodion PF; Andry G; Chantrain G; Dor P; Buyse M; Van Houtte P; Lemort M; Haesendonck P; Larsimont D
Eur J Surg Oncol; 1989 Dec; 15(6):568-74. PubMed ID: 2480922
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy for head and neck cancer. Comparison of cisplatin + vinblastine + bleomycin versus methotrexate.
Williams SD; Velez-Garcia E; Essessee I; Ratkin G; Birch R; Einhorn LH
Cancer; 1986 Jan; 57(1):18-23. PubMed ID: 2416423
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy of squamous head and neck cancer: a prospective randomized trial comparing cis-platinum and bleomycin with methotrexate and vindesine.
von Heyden HW; Schröder M; Scherpe A; Borghardt J; Beyer JH; Nagel GA; Gerhartz H; Foth B; Kastenbauer E; Westerhausen M
Recent Results Cancer Res; 1985; 98():148-52. PubMed ID: 2412266
[No Abstract] [Full Text] [Related]
14. [Randomized study of cisplatin-based combination chemotherapy for the treatment of planocellular cancer of the head and neck region].
Olasz L; Németh A; Nyárády Z; Tornóczky T; Királyfalvi L
Orv Hetil; 2000 Nov; 141(45):2433-7. PubMed ID: 11111384
[TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy or chemotherapy and radiotherapy in advanced head and neck tumors. A prospective, randomized study comparing the 2 therapeutic modalities].
Klima A; von Ilberg C; Bergmann L; Zoubek A; Klippstein T; Mitrou PS; Szepesi S
HNO; 1987 Feb; 35(2):78-83. PubMed ID: 2437086
[TBL] [Abstract][Full Text] [Related]
16. Epirubicin, methotrexate and bleomycin in the management of recurrent squamous cell head and neck cancer. A GSTTC randomised phase II study.
Paccagnella A; Pappagallo GL; Segati R; Zorat P; Cavaniglia G; Lunghi F; Migliorini V; Frattina A; Bianco A; Sileni VC
Eur J Cancer; 1993; 29A(5):704-8. PubMed ID: 7682427
[TBL] [Abstract][Full Text] [Related]
17. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.
Vokes EE; Weichselbaum RR; Mick R; McEvilly JM; Haraf DJ; Panje WR
J Natl Cancer Inst; 1992 Jun; 84(11):877-82. PubMed ID: 1375657
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
Forastiere AA; Metch B; Schuller DE; Ensley JF; Hutchins LF; Triozzi P; Kish JA; McClure S; VonFeldt E; Williamson SK
J Clin Oncol; 1992 Aug; 10(8):1245-51. PubMed ID: 1634913
[TBL] [Abstract][Full Text] [Related]
19. Sequential methotrexate and 5-fluorouracil with bleomycin and cisplatin in the chemotherapy of advanced squamous cancer of the head and neck.
Vogl SE; Komisar A; Kaplan BH; Engstrom PF; Kasule OH; Stolbach L; Lerner H; Muggia F
Cancer; 1986 Feb; 57(4):706-10. PubMed ID: 2417680
[TBL] [Abstract][Full Text] [Related]
20. Continuous intravenous infusion combination chemotherapy for head and neck squamous cell carcinoma.
Gonzalez MF; Valdivieso JG; Sartiano GP
Oncology; 1984; 41(6):377-82. PubMed ID: 6209601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
